Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 1,851–1,900 of 2,289 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003103	Chemotherapy in Treating Patients With Solid Tumors	completed	Phase 1 / Phase 2	57	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 3, 2013	clinicaltrials
NCT00003105	Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer	completed	Phase 1 / Phase 2	30	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 3, 2013	clinicaltrials